Archiv der Pharmazie · 2011 · 26 citations · 22 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationEnzyme InhibitionHit-to-lead OptimizationLead DiscoveryNatural Product Drug DiscoveryStructure-activity Relationship AnalysisAntioxidant PropertiesFragment Screening LibrariesGelatinase ActivityHuman Health EffectsInhibitor ScreeningMatrix Metalloproteinase InhibitorsSelectivity
In the last 20 years, a great variety of synthetic, low molecular weight MMP inhibitors (MMPIs) have been synthesized and tested, although none has reached clinical utility. Exploration of novel ZBGs and development of non-hydroxamate MMPI has become a focus in current research. It's well-known that polyphenols can produce beneficial effects on human health by their antioxidant properties as well as they have the ability to block gelatinase activity. In this work we tested a series of selected phenols as MMP inhibitors. The most interesting hit (B6) shows sub-micromolar activity against MMP-2 (IC(50) 0.59 ± 0.05 µM, LE = 1.07) and a fairly good selectivity spectrum.
22
Alessio Innocenti, Sevim Beyza Öztürk Sarıkaya, İlhami Gülçın et al. · Bioorganic & Medicinal Chemistry · 2010 · 219 citations · Full text
Zinc‐Binding Groups Modulate Selective Inhibition of MMPs
Arpita Agrawal, Diego Romero‐Perez, Jennifer A. Jacobsen et al. · ChemMedChem · 2008 · 140 citations · Full text
The Design of Inhibitors for Medicinally Relevant Metalloproteins
F.E. Jacobsen, Jana A. Lewis, Seth M. Cohen · ChemMedChem · 2006 · 127 citations